Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–10 of 10 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07300241
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +23 more
- Locations
-
- NEO-811 Los Angeles Site Duarte, California, United States
- NEO-811 San Diego Site San Diego, California, United States
- NEO-811 Connecticut Site New Haven, Connecticut, United States
- NEO-811 Chicago Site Zion, Illinois, United States
NCT06949215
- Conditions
- Complex Renal Cyst, ccRCC
- Locations
-
- Peking Union Medical College Beijing, China
Recruiting
Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC
NCT07197580
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +23 more
- Locations
-
- Westmead Hospital Sydney, New South Wales, Australia
- Wollongong Hospital Wollongong, New South Wales, Australia
- Austin Health Heidelberg, Victoria, Australia
- Melbourne Theranostic Innovation Centre (MTIC) Melbourne N., Victoria, Australia
Not Yet Recruiting
CAIX PET/CT for Residual or Recurrent Post-ablative ccRCC
NCT07077083
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Not Yet Recruiting
Pembrolizumab Plus Lenvatinib in REcurrent ccRCC Patients Failing permbroLizUmab aDjuvant trEatment
NCT07460206
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
Not specified
NCT06791863
- Conditions
- ccRCC
- Locations
-
- Wuhan Union Hospital Wuhan, Hubei, China
NCT06775574
- Conditions
- ccRCC
- Locations
-
- Wuhan Union Hospital Wuhan, Hubei, China
NCT03108066
- Conditions
- Abnormalities, Multiple, Adenocarcinoma, Angiomatosis, +35 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Active, Not Recruiting
A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)
NCT02974738
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Astrocytoma, +39 more
- Locations
-
Not specified
Active, Not Recruiting
A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)
NCT02293980
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
- University of Colorado Cancer Center Aurora, Colorado, United States
- Yale School of Medicine New Haven, Connecticut, United States
- University of Miami - Sylvester Comprehensive Cancer Center Miami, Florida, United States